These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34070679)

  • 1. Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin.
    Feitz WJC; van Setten PA; van der Velden TJAM; Licht C; van den Heuvel LPJW; van de Kar NCAJ
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular Endothelium.
    Volokhina EB; Feitz WJC; Elders LM; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32635212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin
    Feitz WJC; Bouwmeester R; van der Velden TJAM; Goorden S; Licht C; van den Heuvel LPJW; van de Kar NCAJ
    Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells.
    Feitz WJC; van de Kar NCAJ; Cheong I; van der Velden TJAM; Ortiz-Sandoval CG; Orth-Höller D; van den Heuvel LPJW; Licht C
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin
    Wijnsma KL; Veissi ST; de Wijs S; van der Velden T; Volokhina EB; Wagener FADTG; van de Kar NCAJ; van den Heuvel LP
    Front Immunol; 2020; 11():547406. PubMed ID: 33414780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Shiga toxin-induced human renal-specific microvascular injury.
    Whelan R; Lih D; Xue J; Himmelfarb J; Zheng Y
    Integr Biol (Camb); 2024 Jan; 16():. PubMed ID: 38266067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
    Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells.
    Amaral MM; Sacerdoti F; Jancic C; Repetto HA; Paton AW; Paton JC; Ibarra C
    PLoS One; 2013; 8(7):e70431. PubMed ID: 23936204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
    Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
    Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions.
    Álvarez RS; Sacerdoti F; Jancic C; Paton AW; Paton JC; Ibarra C; Amaral MM
    PLoS One; 2016; 11(6):e0158180. PubMed ID: 27336788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.
    Te Loo DM; Monnens L; van der Velden T; Karmali M; van den Heuvel L; van Hinsbergh V
    Pediatr Nephrol; 2006 Dec; 21(12):1815-23. PubMed ID: 16944213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Buelli S; Zoja C; Remuzzi G; Morigi M
    Microorganisms; 2019 Jan; 7(1):. PubMed ID: 30634669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
    Ray PE; Liu XH
    Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.